Records containing: Stage III Renal Cell Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-23
Phase II Trial of Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Selected Solid Tumor Malignancies
CLINICAL_TRIALS study record update · 2026-04-02
MDSC Clinical Assay for Cancer Detection and Monitoring in Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2025-12-08
A Phase I Trial of Interleukin-2 (Aldesleukin) and Pembrolizumab Combination Therapy for Patients With Advanced Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2025-06-12
89Zr-DFO-GmAb PET/CT vs Contrast-Enhanced CT for Detection of Recurrent Clear Cell Renal Cell Carcinoma After Surgery
CLINICAL_TRIALS study record update · 2025-05-15
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2023-12-06
A Phase I Study to Evaluate the Safety of Trigriluzole (FC-4157/BHV-4157) in Combination With PD-1 Blocking Antibodies
CLINICAL_TRIALS study record update · 2023-04-11
Pilot Study of Renal Neoplasms With Perfusion Magnetic Resonance Imaging
CLINICAL_TRIALS study record update · 2022-08-15
A Pilot Clinical Trial of Neoadjuvant Tivozanib in Localized Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2022-08-05
Phase I Study of Dalteparin, A Low Molecular Weight Heparin (LMWH), in Combination With Sunitinib (SU11248), an Oral, Selective Multi-targeted Tyrosine Kinase Inhibitor, as First Line Treatment, in Patients With Metastatic Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2021-11-24
A Pilot Study of Neoadjuvant sEphB4-HSA in Patients With Genitourinary Cancers
CLINICAL_TRIALS study record update · 2020-01-23
A Randomized Trial of a Family Caregiver Palliative Care Intervention
CLINICAL_TRIALS study record update · 2019-09-10
Low-Dose TBI and Fludarabine Followed by Unrelated Donor Stem Cell Transplantation for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial
CLINICAL_TRIALS study record update · 2019-06-25
An Imaging and Histopathologic Study to Predict Response to Sunitinib Therapy in Patients With Metastatic or Locally Advanced Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2019-06-06
A Pilot Study of a Rapid Access Platform for Investigational Drugs (RAPID) in Advanced Cancers
CLINICAL_TRIALS study record update · 2019-01-03
Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination With Erlotinib in Papillary Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2019-01-03
An Exploratory Study of the Role of 18F-FSPG PET/CT Imaging for Cancer Patients Receiving Therapy
CLINICAL_TRIALS study record update · 2018-10-15
Safety and Compliance of Patients Treated With Oral Route Anti Cancer Drugs.
CLINICAL_TRIALS study record update · 2018-09-12
A Phase II Study of Pazopanib to Enable Partial Nephrectomy
CLINICAL_TRIALS study record update · 2018-07-03
A Phase 1, Open-Label, Dose-Ranging Study to Assess the Safety and Immunologic Activity of APN401
CLINICAL_TRIALS study record update · 2017-10-10
Pharmacodynamic Study of Sunitinib Malate in Patients With Renal Cell Cancer and Other Advanced Solid Malignancies
CLINICAL_TRIALS study record update · 2017-09-15
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
CLINICAL_TRIALS study record update · 2017-06-14
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
CLINICAL_TRIALS study record update · 2017-05-17
A Phase I/II Study of the HDAC Inhibitor LBH-589 in Combination With the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2017-02-03
Phase II Evaluation of Real-Time, Pharmacokinetically Guided Everolimus in Patients With Hormone Receptor Positive Breast Cancer, Pancreatic Neuroendocrine Tumors (PNET), and Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2016-06-13
Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.